Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$615M |
| 2 |
Uber
UBER
|
+$551M |
| 3 |
Expedia Group
EXPE
|
+$523M |
| 4 |
PayPal
PYPL
|
+$452M |
| 5 |
Eaton
ETN
|
+$408M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$681M |
| 2 |
RTN
Raytheon Company
RTN
|
+$543M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$537M |
| 4 |
Charter Communications
CHTR
|
+$472M |
| 5 |
SPDR Gold Trust
GLD
|
+$464M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.14% |
| 2 | Financials | 4.52% |
| 3 | Industrials | 4.17% |
| 4 | Healthcare | 3.91% |
| 5 | Consumer Discretionary | 3.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6051
Tapestry
TPR
$31.1B
| $702K | ﹤0.01% |
26,017
-1,751,522
| -99% | -$45.7M |
|
6052
PUT
Thomson Reuters
TRI
$44.4B
| $702K | ﹤0.01% |
9,301
+6,454
| +227% | +$470K |
|
6053
Crinetics Pharmaceuticals
CRNX
$8.96B
| $701K | ﹤0.01% |
27,928
+295
| +1% | +$5.62K |
|
6054
Invesco S&P 500 BuyWrite ETF
PBP
$362M
| $701K | ﹤0.01% |
32,531
+9,087
| +39% | +$200K |
|
6055
Pinnacle West Capital
PNW
$12.2B
| $701K | ﹤0.01% |
7,797
-74,927
| -91% | -$6.76M |
|
|
KDFI
6056
DELISTED
KFA Dynamic Fixed Income ETF
KDFI
| $701K | ﹤0.01% |
+28,161
| New | +$703K |
|
6057
AC Immune
ACIU
$263M
| $700K | ﹤0.01% |
82,168
-38,169
| -32% | -$254K |
|
6058
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$271M
| $700K | ﹤0.01% |
15,441
-19,148
| -55% | -$835K |
|
6059
CALL
Heron Therapeutics
HRTX
$66.3M
| $700K | ﹤0.01% |
29,800
-3,800
| -11% | -$84.1K |
|
6060
JPMorgan Diversified Return International Equity ETF
JPIN
$375M
| $700K | ﹤0.01% |
12,267
-39,392
| -76% | -$2.18M |
|
6061
TherapeuticsMD
TXMD
$24M
| $700K | ﹤0.01% |
5,781
+2,000
| +53% | +$288K |
|
|
PRAH
6062
CALL
DELISTED
PRA Health Sciences, Inc.
PRAH
| $700K | ﹤0.01% |
6,300
-3,300
| -34% | -$339K |
|
6063
Invesco Oil & Gas Services ETF
PXJ
$64.8M
| $699K | ﹤0.01% |
24,997
+11,585
| +86% | +$283K |
|
6064
PUT
ProShares Ultra Real Estate
URE
$58.1M
| $699K | ﹤0.01% |
8,000
+4,100
| +105% | +$352K |
|
6065
CALL
Vistra
VST
$49.1B
| $699K | ﹤0.01% |
30,400
+20,500
| +207% | +$529K |
|
6066
Aptus Behavioral Momentum ETF
ADME
$307M
| $698K | ﹤0.01% |
+22,760
| New | +$690K |
|
6067
PUT
Paysign
PAYS
$714M
| $698K | ﹤0.01% |
68,800
+7,900
| +13% | +$83K |
|
|
FPRX
6068
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $698K | ﹤0.01% |
152,014
-67,756
| -31% | -$268K |
|
6069
ProShares UltraShort FTSE China 50 of ProShares Trust
FXP
$6.05M
| $697K | ﹤0.01% |
6,458
+236
| +4% | +$29.1K |
|
6070
CALL
Inogen
INGN
$155M
| $697K | ﹤0.01% |
10,200
-8,700
| -46% | -$546K |
|
6071
CALL
Liberty Latin America Class A
LILA
$1.7B
| $697K | ﹤0.01% |
56,381
-66,063
| -54% | -$768K |
|
6072
National Healthcare
NHC
$3.43B
| $697K | ﹤0.01% |
+8,062
| New | +$674K |
|
|
BITA
6073
CALL
DELISTED
Bitauto Holdings Limited
BITA
| $697K | ﹤0.01% |
47,000
-50,600
| -52% | -$764K |
|
6074
Honda
HMC
$40.6B
| $696K | ﹤0.01% |
+24,574
| New | +$684K |
|
6075
Old Second Bancorp
OSBC
$1.31B
| $696K | ﹤0.01% |
51,676
-20,118
| -28% | -$251K |
|
Similar funds
Citadel Advisors's Q4 2019 Portfolio in Review
As of Q4 2019, Citadel Advisors held 10,299 positions worth $230B, up 8.7% from $212B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors withdrew a net $8.18B in Q4 2019, closing 1,266 positions and reducing 4,117 holdings. Its most notable exit was Celgene Corp, an estimated $681M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.1% of assets, down from 5.3% a quarter earlier, followed by Financials and Industrials.
Against the trend, Citadel Advisors opened a new position in Interxion Holding N.V. worth $83.9M.
- Citadel Advisors's largest Q4 2019 buy was Interxion Holding N.V.: 1,000,931 shares worth $83.9M.
- Citadel Advisors added most to Amazon in Q4 2019, an estimated $615M increase.
- Citadel Advisors's biggest Q4 2019 reduction was Raytheon Company, cutting an estimated $543M.
- Citadel Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $681M.
- Citadel Advisors's ten largest holdings make up 23% of its $230B portfolio in Q4 2019.
- Citadel Advisors opened 1,220 new positions and closed 1,266 in Q4 2019.
- Citadel Advisors's portfolio value rose 8.7% quarter-over-quarter to $230B.
Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.